SAR-Aortech Int. PLC-Rplcmt

3i Group PLC 17 October 2000 The following amendment should be made to the 'SAR - Aortech International PLC' announcement released today at 12:12 under RNS No 6221S. The disclosure should have been on a SAR 5 form and related to the sale of 75,000 shares and not on a SAR 3 form relating to the acquisition of 75,000 shares as previously published. All other details remain unchanged. The full corrected version is shown below. ------------------------------------------------------------------------------- FORM SAR 5 Date of disclosure 17 OCTOBER 2000 DISCLOSURE UNDER NOTE 3 OF RULE 5 OF THE RULES GOVERNING SUBSTANTIAL ACQUISITIONS OF SHARES ('SARs') Date of sale 13.10.00 Sale of AORTECH INTERNATIONAL PLC (name of company) (1) Class of voting shares Number of shares/rights If rights over shares (eg ordinary shares) over shares sold sold, as opposed to the shares themselves, specify nature of rights ORDS 25P 75,000 shares rights N/A (2) Resultant total holding Resultant total holding Total percentage of voting shares (and % of rights over shares of total voting shares (and % of total voting in issue) shares in issue) 5,116,678 (16.97%) N/A ( %) 16.97% ( %) (3) Party making disclosure 3I GROUP PLC (4) (a) Name of person selling shares or rights over shares 3I GROUP PLC and, if different, beneficial owner. (b) Names of any other persons acting by agreement or understanding 3I BIOSCIENCE INVESTMENT TRUST PLC Signed, for and on behalf of the party named in (3) above (Also print name of signatory) J DAVIES Telephone and extension number 0207 928 3131 For full details of the SARs disclosure requirements, see Rules 3 and 5 of the SARs. If in doubt, contact the Panel on Takeovers and Mergers, Tel. No: 020 7382 9026.

Companies

3i Group (III)
UK 100

Latest directors dealings